Skip to content
Home/Companies/Biotech/Centogene

Centogene

Biotech·Germany·Exited 2019·Held 2yr
Entry
2017
Hold
2yr
Exit
2019

Who owns Centogene?

Centogene is a German Biotech company, formerly owned by DPE Deutsche Private Equity, exited in 2019 (exit via IPO). No current private equity owner is on file.

Hand-verified · updated 2026-07-03

Open JSON · CC-BY
DPE Deutsche Private Equity
Investor
DPE Deutsche Private Equity
DPE Fund III · 2017 · Buyout

Key facts

HQGermany
SectorBiotech
StatusAcquired
Exit Type
IPO
Exit Year
2019

More from DPE Fund III

Other portfolio companies in the same fund.

Ortheum
Ortheum
Active
HealthcareGermany· 2022
BplusL
BplusL
Active
Business ServicesGermany· 2020
Mehler Vario System
Active
Aerospace & DefenceGermany· 2020
Mehler Vario Systems
Mehler Vario Systems
Active
Aerospace & DefenceGermany· 2020
VTU Group
Exited 2023
Business ServicesAustria· 2020
to Altor
BE-terna
Exited 2022
IT ServicesAustria· 2019
to Telefonica Tech

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Centogene?

Centogene was formerly owned by DPE Deutsche Private Equity, exited in 2019. No current private equity owner is on file.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue